Published in J Med Microbiol on September 01, 2001
Innate immune responses to Pseudomonas aeruginosa infection. Microbes Infect (2011) 1.33
Interleukin-18 impairs the pulmonary host response to Pseudomonas aeruginosa. Infect Immun (2003) 1.10
Type II secretion system of Pseudomonas aeruginosa: in vivo evidence of a significant role in death due to lung infection. J Infect Dis (2011) 0.94
Protective effect of DNA vaccine encoding pseudomonas exotoxin A and PcrV against acute pulmonary P. aeruginosa Infection. PLoS One (2014) 0.78
Once versus thrice daily gentamicin in patients with serious infections. Lancet (1993) 4.92
Tired of Lyme borreliosis. Lyme borreliosis in the Netherlands. Neth J Med (2011) 2.86
Sonic hedgehog regulates gastric gland morphogenesis in man and mouse. Gastroenterology (2001) 2.85
Induction of thromboses within renal grafts by high-dose prophylactic OKT3. Lancet (1992) 2.66
Efficacy and safety of retreatment with anti-tumor necrosis factor antibody (infliximab) to maintain remission in Crohn's disease. Gastroenterology (1999) 2.62
The vagus nerve and nicotinic receptors modulate experimental pancreatitis severity in mice. Gastroenterology (2006) 2.47
Delayed cerebral thrombosis after initial good recovery from pneumococcal meningitis. Neurology (2009) 2.26
Short-course antibiotic treatment in acute exacerbations of chronic bronchitis and COPD: a meta-analysis of double-blind studies. Thorax (2008) 2.24
Divergent effect of bacillus Calmette-Guérin (BCG) vaccination on Mycobacterium tuberculosis infection in highly related macaque species: implications for primate models in tuberculosis vaccine research. Proc Natl Acad Sci U S A (2001) 2.21
Prevention of antibiotic-associated diarrhea by Saccharomyces boulardii: a prospective study. Gastroenterology (1989) 2.03
Interleukin-1 signaling is essential for host defense during murine pulmonary tuberculosis. J Infect Dis (2000) 2.00
Depletion of alveolar macrophages exerts protective effects in pulmonary tuberculosis in mice. J Immunol (2001) 1.95
Pathogenesis of disseminated intravascular coagulation in sepsis. JAMA (1993) 1.88
Genetic analysis of inflammatory bowel disease in a large European cohort supports linkage to chromosomes 12 and 16. Gastroenterology (1998) 1.73
Leptin is a growth factor for colonic epithelial cells. Gastroenterology (2001) 1.71
Antiinflammatory effects of reconstituted high-density lipoprotein during human endotoxemia. J Exp Med (1996) 1.70
Proinflammatory effects of IL-10 during human endotoxemia. J Immunol (2000) 1.69
Local activation of coagulation and inhibition of fibrinolysis in the lung during ventilator associated pneumonia. Thorax (2004) 1.63
Antigens in culture supernatant of Mycobacterium tuberculosis: epitopes defined by monoclonal and human antibodies. J Gen Microbiol (1990) 1.54
Serum concentrations of cytokines in patients with active tuberculosis (TB) and after treatment. Clin Exp Immunol (1999) 1.53
Elevated plasma concentrations of interferon (IFN)-gamma and the IFN-gamma-inducing cytokines interleukin (IL)-18, IL-12, and IL-15 in severe melioidosis. J Infect Dis (1999) 1.51
Inhibition of endotoxin-induced activation of coagulation and fibrinolysis by pentoxifylline or by a monoclonal anti-tissue factor antibody in chimpanzees. J Clin Invest (1994) 1.50
Piperacillin to prevent cholangitis after endoscopic retrograde cholangiopancreatography. A randomized, controlled trial. Ann Intern Med (1996) 1.48
Clinical relevance of antibiotic-induced endotoxin release. Antimicrob Agents Chemother (1994) 1.48
Interleukin-6 stimulates coagulation, not fibrinolysis, in humans. Thromb Haemost (1996) 1.47
Rituximab as induction therapy after renal transplantation: a randomized, double-blind, placebo-controlled study of efficacy and safety. Am J Transplant (2015) 1.47
Detection of enterotoxigenic Escherichia coli in stool samples by using nonradioactively labeled oligonucleotide DNA probes and PCR. J Clin Microbiol (1994) 1.45
Typhoid fever complicated by intestinal perforation: a persisting fatal disease requiring surgical management. Rev Infect Dis (1985) 1.44
Distribution and spread of colonic lesions in shigellosis: a colonoscopic study. J Infect Dis (1984) 1.42
[Severe phenytoin intoxication in patients with hypoalbuminaemia]. Ned Tijdschr Geneeskd (2007) 1.40
Early switch from intravenous to oral antibiotics: guidelines and implementation in a large teaching hospital. J Antimicrob Chemother (1999) 1.39
[Selective intestinal decontamination prevents death in intensive care patients]. Ned Tijdschr Geneeskd (1999) 1.38
Three vs. 10 days of amoxycillin-clavulanic acid for type 1 acute exacerbations of chronic obstructive pulmonary disease: a randomised, double-blind study. Clin Microbiol Infect (2007) 1.38
Evaluation of different tests for the serodiagnosis of tuberculosis and the use of likelihood ratios in serology. Am Rev Respir Dis (1993) 1.38
The impact of diabetes on the pathogenesis of sepsis. Eur J Clin Microbiol Infect Dis (2011) 1.33
Tumor necrosis factor in sepsis: mediator of multiple organ failure or essential part of host defense? Shock (1995) 1.32
Maintenance infliximab does not result in increased abscess development in fistulizing Crohn's disease: results from the ACCENT II study. Aliment Pharmacol Ther (2006) 1.32
Release of tumor necrosis factor alpha and interleukin 6 during antibiotic killing of Escherichia coli in whole blood: influence of antibiotic class, antibiotic concentration, and presence of septic serum. Infect Immun (1995) 1.30
[An outbreak of Q fever in The Netherlands--possible link to goats]. Ned Tijdschr Geneeskd (2007) 1.29
The mannose cap of mycobacterial lipoarabinomannan does not dominate the Mycobacterium-host interaction. Cell Microbiol (2007) 1.29
Release of urokinase plasminogen activator receptor during urosepsis and endotoxemia. Kidney Int (2001) 1.26
Elevated chemokine concentrations in sera of human immunodeficiency virus (HIV)-seropositive and HIV-seronegative patients with tuberculosis: a possible role for mycobacterial lipoarabinomannan. Infect Immun (1999) 1.26
Campylobacter jejuni diarrhea model in infant chickens. Infect Immun (1984) 1.26
Cytokine release syndrome induced by the 145-2C11 anti-CD3 monoclonal antibody in mice: prevention by high doses of methylprednisolone. J Immunol (1991) 1.22
Attenuation of proinflammatory response by recombinant human IL-10 in human endotoxemia: effect of timing of recombinant human IL-10 administration. J Immunol (1997) 1.21
Struggling with recurrent Clostridium difficile infections: is donor faeces the solution? Euro Surveill (2009) 1.20
The in vivo kinetics of tissue factor messenger RNA expression during human endotoxemia: relationship with activation of coagulation. Blood (2000) 1.18
[Treatment of recurrent Clostridium difficile-associated diarrhoea with a suspension of donor faeces]. Ned Tijdschr Geneeskd (2008) 1.18
Tumor necrosis factor and interleukin-1 inhibitors as markers of disease activity of tuberculosis. Am J Respir Crit Care Med (1998) 1.17
The cytokine-mediated imbalance between coagulant and anticoagulant mechanisms in sepsis and endotoxaemia. Eur J Clin Invest (1997) 1.17
Antibiotic-induced endotoxin release in patients with gram-negative urosepsis: a double-blind study comparing imipenem and ceftazidime. J Infect Dis (1995) 1.16
TNF-alpha compensates for the impaired host defense of IL-1 type I receptor-deficient mice during pneumococcal pneumonia. J Immunol (2001) 1.16
Rapid diagnosis of Legionnaires' disease using an immunochromatographic assay for Legionella pneumophila serogroup 1 antigen in urine during an outbreak in the Netherlands. J Clin Microbiol (2000) 1.16
Double blind trial of loperamide for treating acute watery diarrhoea in expatriates in Bangladesh. Gut (1989) 1.15
IC14, an anti-CD14 antibody, inhibits endotoxin-mediated symptoms and inflammatory responses in humans. J Immunol (2001) 1.14
New insights into pathways that determine the link between infection and thrombosis. Neth J Med (2012) 1.13
Glomerulopathy associated with parasitic infections. Clin Microbiol Rev (2000) 1.13
Validation and nephrotoxicity of a simplified once-daily aminoglycoside dosing schedule and guidelines for monitoring therapy. Antimicrob Agents Chemother (1996) 1.13
Biomaterial-associated persistence of Staphylococcus epidermidis in pericatheter macrophages. J Infect Dis (2000) 1.12
Disseminated intravascular coagulation. Thromb Haemost (1999) 1.12
Assessment of splenic function. Eur J Clin Microbiol Infect Dis (2010) 1.12
Lyme borreliosis vaccination: the facts, the challenge, the future. Trends Parasitol (2010) 1.12
Experimental pneumococcal meningitis in mice: a model of intranasal infection. J Infect Dis (2001) 1.11
Rage signalling promotes intestinal tumourigenesis. Oncogene (2012) 1.11
p38 mitogen-activated protein kinase inhibition increases cytokine release by macrophages in vitro and during infection in vivo. J Immunol (2001) 1.10
Colony stimulating factor-1 in the induction of lupus nephritis. Kidney Int (1993) 1.10
Detection of Campylobacter jejuni and other potential pathogens in travellers' diarrhoea in Bangladesh. Scand J Gastroenterol Suppl (1983) 1.10
Endothelial barrier dysfunction in septic shock. J Intern Med (2015) 1.09
Disturbed alveolar fibrin turnover during pneumonia is restricted to the site of infection. Eur Respir J (2004) 1.08
Interleukin-10 inhibits activation of coagulation and fibrinolysis during human endotoxemia. Blood (1997) 1.06
Increased jejunal prostaglandin E2 concentrations in patients with acute cholera. Gut (1985) 1.06
Altered expression of interferon-gamma and interleukin-4 in inflammatory bowel disease. Inflamm Bowel Dis (1998) 1.06
Guidelines for adults on self-medication for the treatment of acute diarrhoea. Aliment Pharmacol Ther (2001) 1.05
The CXC chemokines gamma interferon (IFN-gamma)-inducible protein 10 and monokine induced by IFN-gamma are released during severe melioidosis. Infect Immun (2000) 1.05
Toll-like receptor mRNA levels in alveolar macrophages after inhalation of endotoxin. Eur Respir J (2006) 1.04
Effect of acute hyperglycaemia and/or hyperinsulinaemia on proinflammatory gene expression, cytokine production and neutrophil function in humans. Diabet Med (2008) 1.02
Causes of death in diarrhoeal diseases after rehydration therapy: an autopsy study of 140 patients in Bangladesh. Bull World Health Organ (1987) 1.02
Meningeal and perivascular macrophages of the central nervous system play a protective role during bacterial meningitis. J Immunol (2001) 1.02
Soluble receptors for tumor necrosis factor as predictors of progression to AIDS in asymptomatic human immunodeficiency virus type 1 infection. J Infect Dis (1994) 1.01
Manifestations of Fabry disease in placental tissue. J Inherit Metab Dis (2006) 1.01
Leptospirosis in travelers. Clin Infect Dis (1994) 1.01
Autoreactive kidney-infiltrating T-cell clones in murine lupus nephritis. Kidney Int (1992) 1.01
Soluble receptors for tumour necrosis factor: a putative marker of disease progression in HIV infection. AIDS (1993) 1.00
Endotoxin and the release of tumor necrosis factor receptors. Prog Clin Biol Res (1994) 1.00
Preferential protection of Borrelia burgdorferi sensu stricto by a Salp15 homologue in Ixodes ricinus saliva. J Infect Dis (2008) 1.00
Serum concentrations of lipopolysaccharide activity-modulating proteins during tuberculosis. J Infect Dis (1998) 1.00
A retrospective, cohort-based survey of patients using twice-daily indinavir + ritonavir combinations: pharmacokinetics, safety, and efficacy. J Acquir Immune Defic Syndr (2001) 1.00
Selective digestive decontamination in patients in intensive care. The Dutch Working Group on Antibiotic Policy. J Antimicrob Chemother (2000) 1.00